Home / Inspections / 1103039

FDA Inspection 1103039 — Strides Pharma, Inc.

Strides Pharma, Inc. — FEI 2434223

The FDA completed an inspection of Strides Pharma, Inc. on August 23, 2019 in Chestnut Ridge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chestnut Ridge, NY (United States)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1162483 (VAI Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1092153 (VAI Wed Jun 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1009619 (VAI Thu Mar 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 932525 (VAI Thu Jun 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 817330 (VAI Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources